Hospital
Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $23.66M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 25% of everything it billed.
33Billing provider infoCATHOLIC HEALTH INITIATIVES COLORADO
PUEBLO, CO 81004
PUEBLO, CO 81004
33aNPI1306857974assigned 08/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.66M
24GClaims593,916
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#8 of 51
Median peer was paid$1.24M
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHERT, TADD controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,238 | $2.94M | |
| 2019 | 76,834 | $2.94M | |
| 2020 | 60,955 | $2.27M | |
| 2021 | 70,703 | $2.57M | |
| 2022 | 90,725 | $4.49M | |
| 2023 | 103,696 | $4.38M | |
| 2024incomplete | 102,765 | $4.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 25% | 24,051 | 21,602 | $5.86M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 47,098 | 43,958 | $5.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 24,836 | 22,916 | $2.45M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.0% | 12,711 | 11,920 | $1.42M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5.9% | 3,925 | 3,600 | $1.40M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.7% | 12,599 | 11,689 | $1.35M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 13,694 | 12,585 | $1.34M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 3,260 | 3,024 | $562K |
| 80053 | Comprehensive metabolic panel | 2.3% | 41,681 | 38,088 | $534K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 2,133 | 2,033 | $435K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 3,927 | 3,740 | $300K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.2% | 439 | 423 | $283K |
127 more codes
| 50590 | <1% | 119 | $227K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,395 | $220K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,095 | $215K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,733 | $213K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,410 | $190K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,915 | $189K |
| 84484 | <1% | 14,121 | $170K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,695 | $158K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 968 | $149K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,943 | $119K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 963 | $114K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,387 | $89K |
| 83605 | <1% | 7,260 | $80K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 208 | $74K |
| 64635 | <1% | 197 | $44K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 580 | $36K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,061 | $34K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 132 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20,283 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 10,189 | $15K |
| 87040 | <1% | 1,832 | $15K | |
| 80320 | <1% | 146 | $14K | |
| 87400 | <1% | 532 | $11K | |
| 77336 | <1% | 178 | $11K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $9K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 426 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 31,026 | $8K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 71 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 23,418 | $7K |
| 93975 | <1% | 44 | $5K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 25 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 151 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 51,571 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,127 | $3K |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 239 | $2K |
| 0002A | <1% | 39 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,804 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 38,844 | $2K |
| 81001 | <1% | 14,743 | $2K | |
| 80047 | <1% | 87 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 267 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 15 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 74 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,847 | $2K |
| 0001A | <1% | 32 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16,272 | $1K |
| 73630 | <1% | 31 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,535 | $1K |
| 85379 | <1% | 296 | $1K | |
| 93971 | <1% | 13 | $1K | |
| 97597 | <1% | 51 | $961.94 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 651 | $857.23 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 25 | $840.65 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 41 | $797.98 |
| 83690 | <1% | 15,488 | $708.40 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $688.90 |
| 81003 | <1% | 7,229 | $662.86 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,705 | $512.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,977 | $435.55 |
| 93017 | <1% | 12 | $399.61 | |
| 80076 | <1% | 47 | $399.51 | |
| 81025 | <1% | 4,236 | $395.28 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $377.95 |
| 90715 | <1% | 25 | $365.18 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,665 | $341.28 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,301 | $328.56 |
| 84145 | <1% | 52 | $263.64 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 276 | $238.58 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 759 | $201.17 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 6,278 | $200.46 |
| 87807 | <1% | 263 | $198.48 | |
| 84703 | <1% | 3,807 | $177.23 | |
| 87081 | <1% | 269 | $148.91 | |
| 82077 | <1% | 2,078 | $135.41 | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,999 | $91.05 |
| 80050 | General health panel | <1% | 248 | $86.56 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,165 | $70.84 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 775 | $48.50 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 550 | $40.48 |
| 86140 | <1% | 771 | $35.16 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 43 | $32.51 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 588 | $30.36 |
| 85610 | <1% | 392 | $15.56 | |
| 80305 | <1% | 722 | $11.31 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,557 | $10.45 |
| 83735 | <1% | 1,976 | $10.43 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 335 | $10.12 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,246 | $10.12 |
| 82803 | <1% | 1,100 | $7.72 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,778 | $7.22 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 398 | $0.20 |
| 0753T | 0% | 1,375 | $0.00 | |
| 94664 | 0% | 440 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 61 | $0.00 |
| 82248 | 0% | 131 | $0.00 | |
| 64636 | 0% | 358 | $0.00 | |
| 82010 | 0% | 223 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 33 | $0.00 |
| 73562 | 0% | 43 | $0.00 | |
| 73610 | 0% | 44 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 15 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 14 | $0.00 |
| 87186 | 0% | 14 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 40,254 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 679 | $0.00 |
| 83880 | 0% | 773 | $0.00 | |
| 88342 | 0% | 1,278 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 88 | $0.00 |
| 85730 | 0% | 37 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 180 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 97 | $0.00 |
| 96376 | 0% | 300 | $0.00 | |
| 84540 | 0% | 29 | $0.00 | |
| 83615 | 0% | 29 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 290 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 42 | $0.00 |
| 87077 | 0% | 83 | $0.00 | |
| 94760 | 0% | 13 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 96 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 112 | $0.00 |
| 82330 | 0% | 29 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 12 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 44 | $0.00 |
| 90686 | 0% | 15 | $0.00 | |
| C1769 | Guide wire | 0% | 17 | $0.00 |
| A9270 | Non-covered item or service | 0% | 27 | $0.00 |
| 85027 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, TADD (GROUP VP FINANCE)
Parent organizationCATHOLIC HEALTH INITIATIVES
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $25.26M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $8.91M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Canon City, CO | $6.39M |
| Catholic Health Initiatives Colorado | Durango, CO | $5.98M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Initiatives Colorado | Fort Morgan, CO | $1.17M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.